158 related articles for article (PubMed ID: 25060772)
1. T3 levels in relation to prognostic factors in breast cancer: a population-based prospective cohort study.
Tosovic A; Bondeson AG; Bondeson L; Ericsson UB; Manjer J
BMC Cancer; 2014 Jul; 14():536. PubMed ID: 25060772
[TBL] [Abstract][Full Text] [Related]
2. Prospectively measured triiodothyronine levels are positively associated with breast cancer risk in postmenopausal women.
Tosovic A; Bondeson AG; Bondeson L; Ericsson UB; Malm J; Manjer J
Breast Cancer Res; 2010; 12(3):R33. PubMed ID: 20540734
[TBL] [Abstract][Full Text] [Related]
3. Triiodothyronine levels in relation to mortality from breast cancer and all causes: a population-based prospective cohort study.
Tosovic A; Bondeson AG; Bondeson L; Ericsson UB; Manjer J
Eur J Endocrinol; 2013 Apr; 168(4):483-90. PubMed ID: 23258272
[TBL] [Abstract][Full Text] [Related]
4. Prospectively measured thyroid hormones and thyroid peroxidase antibodies in relation to risk of different breast cancer subgroups: a Malmö Diet and Cancer Study.
Brandt J; Borgquist S; Manjer J
Cancer Causes Control; 2015 Aug; 26(8):1093-104. PubMed ID: 26033776
[TBL] [Abstract][Full Text] [Related]
5. Serum vitamin D (25OHD3) levels and the risk of different subtypes of breast cancer: A nested case-control study.
Shirazi L; Almquist M; Borgquist S; Malm J; Manjer J
Breast; 2016 Aug; 28():184-90. PubMed ID: 27326980
[TBL] [Abstract][Full Text] [Related]
6. Association of serum estrone levels with estrogen receptor-positive breast cancer risk in postmenopausal Japanese women.
Miyoshi Y; Tanji Y; Taguchi T; Tamaki Y; Noguchi S
Clin Cancer Res; 2003 Jun; 9(6):2229-33. PubMed ID: 12796390
[TBL] [Abstract][Full Text] [Related]
7. Premorbid body weight and its relations to primary tumour diameter in breast cancer patients; its dependence on estrogen and progesteron receptor status.
Maehle BO; Tretli S; Skjaerven R; Thorsen T
Breast Cancer Res Treat; 2001 Jul; 68(2):159-69. PubMed ID: 11688519
[TBL] [Abstract][Full Text] [Related]
8. Testosterone and biological characteristics of breast cancers in postmenopausal women.
Secreto G; Venturelli E; Meneghini E; Greco M; Ferraris C; Gion M; Zancan M; Fabricio AS; Berrino F; Cavalleri A; Micheli A
Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):2942-8. PubMed ID: 19843675
[TBL] [Abstract][Full Text] [Related]
9. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
Missmer SA; Eliassen AH; Barbieri RL; Hankinson SE
J Natl Cancer Inst; 2004 Dec; 96(24):1856-65. PubMed ID: 15601642
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of progesterone receptor, FOXA1, GATA3, and p53 between pre- and postmenopausal women with estrogen receptor-positive breast cancer.
Hosoda M; Yamamoto M; Nakano K; Hatanaka KC; Takakuwa E; Hatanaka Y; Matsuno Y; Yamashita H
Breast Cancer Res Treat; 2014 Apr; 144(2):249-61. PubMed ID: 24549642
[TBL] [Abstract][Full Text] [Related]
11. Steroid receptor status and its clinicopathological correlation in post-menopausal breast cancer patients of Kumaon region of Uttarakhand.
Shahi KS; Bhandari G; Singh A
J Cancer Res Ther; 2011; 7(1):19-22. PubMed ID: 21546737
[TBL] [Abstract][Full Text] [Related]
12. Prediagnostic aspirin use and mortality in women with stage I to III breast cancer: A cohort study in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Bradley MC; Black A; Freedman AN; Barron TI
Cancer; 2016 Jul; 122(13):2067-75. PubMed ID: 27149646
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic Characteristics of Oestrogen Receptor-Positive/Progesterone Receptor-Negative/Her2-Negative Breast Cancer According to a Novel Definition of Negative Progesterone Receptor Status: A Large Population-Based Study from China.
Li AQ; Zhou SL; Li M; Xu Y; Shui RH; Yu BH; Yang WT
PLoS One; 2015; 10(5):e0125067. PubMed ID: 25938238
[TBL] [Abstract][Full Text] [Related]
14. Predictive factors for sentinel node metastases in primary invasive breast cancer: a population-based cohort study of 2552 consecutive patients.
Majid S; Rydén L; Manjer J
World J Surg Oncol; 2018 Mar; 16(1):54. PubMed ID: 29530065
[TBL] [Abstract][Full Text] [Related]
15. High Ki-67 Expression and Low Progesterone Receptor Expression Could Independently Lead to a Worse Prognosis for Postmenopausal Patients With Estrogen Receptor-Positive and HER2-Negative Breast Cancer.
Nishimukai A; Yagi T; Yanai A; Miyagawa Y; Enomoto Y; Murase K; Imamura M; Takatsuka Y; Sakita I; Hatada T; Miyoshi Y
Clin Breast Cancer; 2015 Jun; 15(3):204-11. PubMed ID: 25600243
[TBL] [Abstract][Full Text] [Related]
16. Thyroid hormones and breast cancer association according to menopausal status and body mass index.
Ortega-Olvera C; Ulloa-Aguirre A; Ángeles-Llerenas A; Mainero-Ratchelous FE; González-Acevedo CE; Hernández-Blanco ML; Ziv E; Avilés-Santa L; Pérez-Rodríguez E; Torres-Mejía G
Breast Cancer Res; 2018 Aug; 20(1):94. PubMed ID: 30092822
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D deficiency is associated with poor breast cancer prognostic features in postmenopausal women.
de Sousa Almeida-Filho B; De Luca Vespoli H; Pessoa EC; Machado M; Nahas-Neto J; Nahas EAP
J Steroid Biochem Mol Biol; 2017 Nov; 174():284-289. PubMed ID: 29031688
[TBL] [Abstract][Full Text] [Related]
18. Biomarker expression and St Gallen molecular subtype classification in primary tumours, synchronous lymph node metastases and asynchronous relapses in primary breast cancer patients with 10 years' follow-up.
Falck AK; Bendahl PO; Chebil G; Olsson H; Fernö M; Rydén L
Breast Cancer Res Treat; 2013 Jul; 140(1):93-104. PubMed ID: 23807420
[TBL] [Abstract][Full Text] [Related]
19. St Gallen molecular subtypes in primary breast cancer and matched lymph node metastases--aspects on distribution and prognosis for patients with luminal A tumours: results from a prospective randomised trial.
Falck AK; Fernö M; Bendahl PO; Rydén L
BMC Cancer; 2013 Nov; 13():558. PubMed ID: 24274821
[TBL] [Abstract][Full Text] [Related]
20. Mammographic breast density and subsequent risk of breast cancer in postmenopausal women according to tumor characteristics.
Yaghjyan L; Colditz GA; Collins LC; Schnitt SJ; Rosner B; Vachon C; Tamimi RM
J Natl Cancer Inst; 2011 Aug; 103(15):1179-89. PubMed ID: 21795664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
